Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series Ltd: World’s leading Event Organizer

Back

Abulizi Abudula

Abulizi Abudula

Xinjiang Medical University, PR China

Title: Protein profile changes among cancer patients after abnormal Savda therapy in traditional Uighur medicine

Biography

Abulizi Abudula has completed his PhD from Jena University and Post-doctoral studies from Bielefeld and Goettingen Universities in Germany. He is working as an invited scholar at the Xinjiang Medical University and involved in the research of cancer early diagnosis, prevention and treatment by traditional Uighur medicine. He has published more than 10 papers in international journals in the fi eld of Tumor Biology and Traditional Medicine.

Abstract

Traditional Uighur medicine shares an origin with Greco-Arab medicine. It describes a disease in terms of Abnormal Hilits (syndromes) that are caused by imbalance of the dynamic homeostasis of four normal Hilits (humors), consisting of Kan, Phlegm, Safra and Savda, which correspond to Blood, Phlegm, Yellow Bile, and Black Bile in Greco-Arab medicine. In the clinical practice, the Abnormal Savda (syndrome), which refers to the change in Black Bile, is the major pathological condition of diseases and can be treated with its unique prescription, composed of Abnormal Savda Munziq and Abnormal Savda Mushil, known as Abnormal Savda therapy. In this study, 29 cancer patients diagnosed with Abnormal Savda underwent Abnormal Savda therapy. According to the criteria in Uighur medicine, the syndrome scores for Abnormal Savda signifi cantly declined aft er treatment. Subsequent proteomic
analysis identifi ed 27 proteins diff erentially expressed in the plasma of patients from baseline to aft er treatment. Bio-informatic analysis indicated that most of these proteins are potential tumor biomarkers. Among the seven proteins detected by enzyme-linked immunosorbent assay, the expression of vWF, APOC4, and THBS1 was signifi cantly upregulated, while ADIPOQ and ITIH3 were downregulated aft er to treatment. We previously reported the down-regulation of vWF and THBS1 and upregulation of ITIH3 in cancer patients diagnosed with Abnormal Savda compared with those with other syndromes and healthy controls. Th erefore, the inverse regulation of protein expression in response to treatment provides evidence for the use of Abnormal Savda therapy as an alternative or auxiliary method to the clinical treatment of cancer patients by Western medicine.